FERROUS Drug Patent Profile
✉ Email this page to a colleague
When do Ferrous patents expire, and what generic alternatives are available?
Ferrous is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in FERROUS is ferrous citrate, fe-59. There are thirteen drug master file entries for this compound. Additional details are available on the ferrous citrate, fe-59 profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FERROUS?
- What are the global sales for FERROUS?
- What is Average Wholesale Price for FERROUS?
Summary for FERROUS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Sales Revenues: | Drug sales revenues for FERROUS |
| DailyMed Link: | FERROUS at DailyMed |
US Patents and Regulatory Information for FERROUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | FERROUS CITRATE FE 59 | ferrous citrate, fe-59 | INJECTABLE;INJECTION | 016729-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
